Denmark· DK-28106129518
Sympagesic
A butyyliskopolamiini ja analgeetti product containing hyoscinbutylbromid, metamizolnatriummonohydrat, registered in Denmark by Dechra Regulatory B.V.. The same ATC class is registered in 2 of our 19 countries.
Checked against Danish Medicines Agency (Denmark) on
Informational only — not a medical device.
Where it is registered
Hyoscinbutylbromid, metamizolnatriummonohydrat is registered in 2 of 19 countries.
Countries holding a registration under ATC QA03DB04 (butyyliskopolamiini ja analgeetti), each read from that country’s own register.
- This record: Denmark, from Danish Medicines Agency (Denmark)
- 1 of them publish a price we can compare per daily dose
Hyoscinbutylbromid, metamizolnatriummonohydrat · ATC QA03DB04
2 / 19 countries
- Denmark
- Finlandprice
The record
At a glance
Danish Medicines Agency (Denmark)- Active substance
- Hyoscinbutylbromid, Metamizolnatriummonohydrat
- Manufacturer
- Dechra Regulatory B.V.
- Country
- Denmark (DK)
- ATC code
- QA03DB04
- ATC class
- Butyyliskopolamiini ja analgeetti
- Reimbursed
- Not published by this register
- Source register
- Danish Medicines Agency (Denmark)
- Last checked
- September 30, 2026
Packs & prices · 1
- dk_varenummer28106129518
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under QA03DB04
Butyyliskopolamiini ja analgeetti, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Danish Medicines Agency (Denmark). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/ca6e9272-bc26-41ad-b54b-343b41caf23e GET /v1/drugs/ca6e9272-bc26-41ad-b54b-343b41caf23e?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "injektionsvæske, opløsning",
"source": "dkma",
"strength": "500+4 mg/ml",
"auth_role": "CMS",
"dk_drugid": "28106129518",
"substance": "Hyoscinbutylbromid, Metamizolnatriummonohydrat",
"auth_procedure": "Decentral procedure",
"in_medicinpriser": false,
"registration_date_serial": "43588"
}See everything about hyoscinbutylbromid, metamizolnatriummonohydrat.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.